Adjuvant chemotherapy extends survival in pancreatic cancer

Adjuvant chemotherapy appeared associated with a significant survival benefit among patients with pancreatic ductal adenocarcinoma who underwent multiagent neoadjuvant chemotherapy and resection, according to study results.Investigators observed the survival benefit regardless patients lymph node status or resection margins.

Related Keywords

Colorado ,United States ,Boston ,Massachusetts ,Japan ,Mochida ,Miyazaki ,Byashley Killen ,Toshitaka Sugawara ,Mark Leiser ,University Of Colorado Department ,Mochida Memorial Foundation For ,Japan Society ,Science Overseas Challenge Program ,Young Researchers ,Mochida Memorial Foundation ,Pharmaceutical Research ,Boston Scientific Sponsored ,Marco Del Chiaro ,